-
Product Insights
Ectopic Pregnancy (Tubal Pregnancy) Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Ectopic Pregnancy (Tubal Pregnancy) Global Clinical Trials Review, H1, 2019" provides an overview of Ectopic Pregnancy (Tubal Pregnancy) clinical trials scenario. This report provides top line data relating to the clinical trials on Ectopic Pregnancy (Tubal Pregnancy). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Endometrial Hyperplasia Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Endometrial Hyperplasia Global Clinical Trials Review, H1, 2019" provides an overview of Endometrial Hyperplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Endometrial Hyperplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Atrophic Vaginitis (Vaginal Atrophy Vulvovaginal Atrophy Urogenital Atrophy) - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Atrophic Vaginitis (Vaginal Atrophy Vulvovaginal Atrophy Urogenital Atrophy) - Global Clinical Trials Review, H2, 2021" provides an overview of Atrophic Vaginitis (Vaginal Atrophy Vulvovaginal Atrophy Urogenital Atrophy) Clinical trials scenario. This report provides top line data relating to the clinical trials on Atrophic Vaginitis (Vaginal Atrophy Vulvovaginal Atrophy Urogenital Atrophy). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials...
-
Product Insights
Vasomotor Symptoms of Menopause (Hot Flashes) - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Vasomotor Symptoms of Menopause (Hot Flashes) - Global Clinical Trials Review, H2, 2021" provides an overview of Vasomotor Symptoms of Menopause (Hot Flashes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Vasomotor Symptoms of Menopause (Hot Flashes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7),...
-
Product Insights
Ovarian Hyperstimulation Syndrome - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Ovarian Hyperstimulation Syndrome - Global Clinical Trials Review, H2, 2021" provides an overview of Ovarian Hyperstimulation Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Hyperstimulation Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type....
-
Product Insights
Amenorrhea - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Amenorrhea - Global Clinical Trials Review, H2, 2021" provides an overview of Amenorrhea Clinical trials scenario. This report provides top line data relating to the clinical trials on Amenorrhea . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Cervical Intraepithelial Neoplasia (CIN) - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Cervical Intraepithelial Neoplasia (CIN) - Global Clinical Trials Review, H2, 2021" provides an overview of Cervical Intraepithelial Neoplasia (CIN) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Intraepithelial Neoplasia (CIN). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status...
-
Product Insights
Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Premature Ovarian Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Premature Ovarian Failure, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Cervical Intraepithelial Neoplasia (CIN) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cervical Intraepithelial Neoplasia Pipeline Drugs Market Overview Cervical Intraepithelial Neoplasia (CIN), also known as cervical dysplasia is characterized by abnormal appearance of cells on the surface of the cervix. Cervical dysplasia usually occurs in women aging twenty five to thirty five. Most cases of cervical dysplasia are caused by human papilloma virus (HPV). Signs and symptoms include genital warts, abnormal bleeding, spotting after intercourse, vaginal discharge, and low back pain. The CIN pipeline drugs market research report provides comprehensive information...
-
Product Insights
Female Contraception Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Female Contraception Pipeline Drugs Market Report Overview Contraception (birth control) prevents pregnancy by interfering with the normal process of ovulation, fertilization, and implantation. There are many contraceptive methods which include implants and injections, intrauterine devices (IUDs), pills and vaginal rings, barrier methods, sterilization, and natural methods. The Female Contraception pipeline drugs market research report provides comprehensive information on the therapeutics under development for Female Contraception, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.